Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Breast (Edinburgh, Scotland)|January 21, 2004
Nipple aspirate fluid in relation to breast cancerH A Phillips, G C Howard, W R Miller
Breast Cancer Research and Treatment|August 15, 2000
Pilot studies on the p53 gene in nipple aspirate fluid from patients with breast cancerH A Phillips, G C Howard, W R Miller
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 1, 1985
Metastatic oligodendroglioma presenting as a leukoerythroblastic anaemiaH F Newman, G C Howard, P M Reid
Clinical Radiology|May 1, 1989
Carcinoma in-situ of the testis diagnosed on semen cytologyG C Howard, T B Hargreave, M A McIntyre
British Journal of Cancer|January 19, 2000
p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancerH A Phillips, G C Howard, W R Miller
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 1, 1987
Hyperthermia and radiation in the treatment of superficial malignancy: an analysis of treatment parameters, response and toxicityG C Howard, V Sathiaseelan, L Freedman, et al.
The British Journal of Radiology|December 1, 1985
A clinical microwave hyperthermia system with multipoint real-time thermal dosimetryV Sathiaseelan, G C Howard, I H Kedar, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 1, 1991
Failure of salvage treatment in metastatic testicular teratomaD Whillis, R E Coleman, M A Cornbleet, et al.
Archives of Biochemistry and Biophysics|September 1, 1996
Characterization of alpha 2-macroglobulin binding to human trabecular meshwork cells: presence of the alpha 2-macroglobulin signaling receptorG C Howard, B C Roberts, D L Epstein, et al.
The Journal of Clinical Investigation|March 1, 1996
Altered interaction of Cis-dichlorodiammineplatinum(II)--modified alpha 2-macroglobulin (alpha 2M) with the low density lipoprotein receptor-related protein/alpha 2M receptor but not the alpha 2M signaling receptorG C Howard, U K Misra, D L DeCamp, et al.
Pageof 5